Evidence map›Paper›PMID 34907900›Full record

ArticleJournal of medical Internet research2022

Health Care Providers' and Professionals' Experiences With Telehealth Oncology Implementation During the COVID-19 Pandemic: A Qualitative Study.

Kea Turner, Margarita Bobonis Babilonia, Cristina Naso, Oliver Nguyen, Brian D Gonzalez, Laura B Oswald, Edmondo Robinson, Jennifer Elston Lafata, Robert J Ferguson, Amir Alishahi Tabriz and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Precision and Virtual Care.Yearbook of medical informatics · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Kea TurnerDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-7885-0879
Margarita Bobonis BabiloniaDepartment of Supportive Care Medicine, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-4950-5179
Cristina NasoVirtual Health Program, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0001-7029-9405
Oliver NguyenDepartment of Health Outcomes and Biomedical Information, University of Florida, Gainesville, FL, United States.ORCID 0000-0003-2852-7106
Brian D GonzalezDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0001-5108-5735
Laura B OswaldDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0001-6281-2512
Edmondo RobinsonDepartment of Internal and Hospital Medicine, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0001-9625-6235
Jennifer Elston LafataDivision of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, United States.ORCID 0000-0002-8550-6195
Robert J FergusonDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.ORCID 0000-0001-9711-022X
Amir Alishahi TabrizDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-6273-9105
Krupal B PatelDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-2285-0386
Julie Hallanger-JohnsonDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-8020-8623
Nasrin AldawoodiDepartment of Anesthesiology, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0003-3569-9440
Young-Rock HongDepartment of Health Services Research, Management and Policy, University of Florida, Tampa, FL, United States.ORCID 0000-0002-0366-5687
Heather S L JimDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0001-7353-3711
Philippe E SpiessDepartment of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-5723-1972
Moffitt Cancer Center · USUniversity of Florida · USUniversity of Florida Health · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapid implementation of telehealth for cancer care during COVID-19 required innovative and adaptive solutions among oncology health care providers and professionals (HPPs).

objectiveThe aim of this qualitative study was to explore oncology HPPs' experiences with telehealth implementation during the COVID-19 pandemic.

methodsThis study was conducted at Moffitt Cancer Center (Moffitt), an NCI (National Cancer Institute)-Designated Comprehensive Cancer Center. Prior to COVID-19, Moffitt piloted telehealth visits on a limited basis. After COVID-19, Moffitt rapidly expanded telehealth visits. Telehealth visits included real-time videoconferencing between HPPs and patients and virtual check-ins (ie, brief communication with an HPP by telephone only). We conducted semistructured interviews with 40 oncology HPPs who implemented telehealth during COVID-19. The interviews were recorded, transcribed verbatim, and analyzed for themes using Dedoose software (version 4.12).

resultsApproximately half of the 40 participants were physicians (n=22, 55%), and one-quarter of the participants were advanced practice providers (n=10, 25%). Other participants included social workers (n=3, 8%), psychologists (n=2, 5%), dieticians (n=2, 5%), and a pharmacist (n=1, 3%). Five key themes were identified: (1) establishing and maintaining patient-HPP relationships, (2) coordinating care with other HPPs and informal caregivers, (3) adapting in-person assessments for telehealth, (4) developing workflows and allocating resources, and (5) future recommendations. Participants described innovative strategies for implementing telehealth, such as coordinating interdisciplinary visits with multiple HPPs and inviting informal caregivers (eg, spouse) to participate in telehealth visits. Health care workers discussed key challenges, such as workflow integration, lack of physical exam and biometric data, and overcoming the digital divide (eg, telehealth accessibility among patients with communication-related disabilities). Participants recommended policy advocacy to support telehealth (eg, medical licensure policies) and monitoring how telehealth affects patient outcomes and health care delivery.

conclusionsTo support telehealth growth, implementation strategies are needed to ensure that HPPs and patients have the tools necessary to effectively engage in telehealth. At the same time, cancer care organizations will need to engage in advocacy to ensure that policies are supportive of oncology telehealth and develop systems to monitor the impact of telehealth on patient outcomes, health care quality, costs, and equity.

Indexed as

COVID-19TelemedicineHealth PersonnelHumansPandemicsSARS-CoV-2cancercoronavirus diseaseCOVID-19digital healthoncologyremote monitoringtelehealthtelemedicineteleoncology

Identifiers

PMID34907900
PMCPMC8772877
OpenAlexW4200586573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.